EXECUTIVE COMMITTEE

Chair: Harold H. Shlevin; President & CEO, Tikvah Therapeutics, Inc.

Thomas H. Callaway, MD; President, Life Science Partner, Inc.

Charles Craig; President, Georgia Bio

William D. Johnston, PhD; President, BioBusiness Strategies

Margie D. Poole; CEO, Informed Horizons, LLC

Phillip H. Street; Partner, Kilpatrick Stockton LLP

Maria Thacker; Marketing and Project Manager, Georgia Bio


PROGRAM COMMITTEE

Co-Chair: Thomas H. Callaway, MD; President, Life Science Partner, Inc.

Co-Chair: Phillip Street; Kilpatrick Stockton LLP

Bob Nerem, PhD; Professor and Director, Georgia Institute of Technology

Brenda Robbins; Senior Project Manager and Economic Development, Georgia Power

Bob McNally, PhD; President, Cell Dynamics, LLC

Margaret K. Offermann, MD, PhD; Professor of Hematology and Onocology, Emory Winship Cancer Institute

Todd Sherer, PhD; Assistant Vice President and Director of Technology Transfer, Emory University

Tim Patrick; President and CEO, Carticept Medical, Inc.

Jakob Vinten-Johansen, PhD, FAHA; Professory Cardiothoracic Surgery and Director Cardiothoracic Research Laboratory, Carlyle Fraser Heart Center

Steven Stice, PhD; Professor and GRA Eminent Scholar, University of Georgia

Bruce Robertson; Managing Director, H.I.G.

Melissa Bishop-Murphy, Esq; Director and Team Leader Government Relations and Public Affairs, Pfizer Inc.


SPONSORSHIP COMMITTEE

Chair: William Johnston; President, BioBusiness Strategies

Charles S. Craig; President, Georgia Bio

Harold Shlevin; President and CEO, Tikvah Therapeutics